0001127602-22-021922.txt : 20220901
0001127602-22-021922.hdr.sgml : 20220901
20220901181934
ACCESSION NUMBER: 0001127602-22-021922
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220901
FILED AS OF DATE: 20220901
DATE AS OF CHANGE: 20220901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIERENGA WENDALL
CENTRAL INDEX KEY: 0001235945
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 221222665
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
STREET 2: C/O NEUROCRINE BIOSCIENCES
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: WIERENGA WENDALL D
DATE OF NAME CHANGE: 20030527
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-09-01
0001061983
CYTOKINETICS INC
CYTK
0001235945
WIERENGA WENDALL
350 OYSTER POINT BLVD
SOUTH SAN FRANCISCO
CA
94080
1
Common Stock
2022-09-01
4
M
0
4166
6.78
A
16336
D
Common Stock
2022-09-01
4
S
0
4166
52.79
D
12170
D
Non-Qualified Stock Option (Right to Buy)
6.78
2022-09-01
4
M
0
4166
0
D
2013-06-22
2023-05-22
Common Stock
4166
0
D
Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
2022-09-01